Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Acetyl-Carnitine and Reduced Neuropathic Pain

Research synthesisLow evidenceModerate effect3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies on acetyl-carnitine for neuropathic pain, 2 reported beneficial effects of moderate size, while 1 found neutral effects. The beneficial findings come from clinical populations with peripheral neuropathies or acute low back trauma. Effects were typically observed at 8 weeks.

  • Studied populations: patients with peripheral neuropathies, patients with acute low back trauma

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. The highest-quality study (a systematic review) showed no benefit, while lower-quality studies (a narrative review and an observational study) reported positive effects. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed).

Generated Jul 12, 2026
Time to effect
Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 3 studies
Safety in these studies
3 of 3 papers
Back to top